An ongoing dialogue on HIV/AIDS, infectious diseases,
March 28th, 2010
Kidneys: Fortunately, We Have Two
Here’s a case over in our Journal Watch: AIDS Clinical Care site: a man with suspected PCP develops rapidly progressive renal failure after being starting on both empiric PCP treatment with TMP-SMX and ART with TDF/FTC plus darunavir/ritonavir.
The specific questions at the end of the case were:
- What do you think is causing the renal failure?
- Would you continue empiric treatment for PCP or try to confirm the diagnosis?
- If you would continue empiric treatment, would you modify it?
- What would you do with his ART? Specifically, would you continue the tenofovir?
- What would be your preferred alternative regimen?
I ran into the nephrologist Jonathan Winston this weekend, who will providing his take on the case shortly. He asked me what actually happened.
Stay tuned …
[Edit: Outcome of case now posted here.]
Paul E. Sax, MD
Contributing Editor
NEJM Journal Watch
Infectious Diseases
Biography | Disclosures | Summaries
Learn more about HIV and ID Observations.
NEJM Journal Watch — Recent Infectious Disease Articles- Anti-Spike Antibodies as Predictors of Risk for SARS-CoV-2 Infection
- Mpox in Africa: Ongoing Epidemiologic Complexity
- Observations from ID and Beyond: This Year Influenza Came Back to Remind Us It's Not Messing Around
- Is Tenofovir Disoproxil Fumarate Best Avoided when Treating Patients with Hepatitis B After Liver Transplantation?
- Does Fluconazole Benefit Adults with Primary Pulmonary Coccidioidomycosis?